Overall, a 2.5 to 5-fold increase in the granzyme B+ CD8+ T cell to Treg ratio in αCD40 and HT40-treated tumors compared to the untreated control was noted, which reflects enhanced mobilization of cytotoxic cells in the treated tumor (Figure 6C). The gene discussed is GZMB; the disease is neoplasm.